Kung‐I Feng

Potent, selective, and orally active adenosine A2A receptor antagonists: Arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines

Bernard R. Neustadt, Jinsong Hao, Neil Lindo et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 135 citations · Full text

Medicine, Mechanism Of Action, Pharmacological Agent +4

Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms

Ling Tong, Wensheng Yu, Lei Chen et al. · Journal of Medicinal Chemistry · 2016 · 47 citations

Medicinal Chemistry, Antiviral Compound, Molecular Virology +14

Effect of composition of simulated intestinal media on the solubility of poorly soluble compounds investigated by design of experiments

Cecilie Maria Madsen, Kung‐I Feng, Andrew Leithead et al. · European Journal of Pharmaceutical Sciences · 2017 · 34 citations

Food Chemistry, Nutrition, Medicine +10

Analyzing the Potential Root Causes of Variability of Pharmacokinetics in Preclinical Species

Pierre Daublain, Kung‐I Feng, Michael D. Altman et al. · Molecular Pharmaceutics · 2017 · 25 citations

Assessing the Utility of In Vitro Screening Tools for Predicting Bio-Performance of Oral Peptide Delivery

Prajakta Gadgil, Candice Alleyne, Kung‐I Feng et al. · Pharmaceutical Research · 2019 · 19 citations

Translational Medicine, Preclinical Drug Evaluation, Medicine +9